Global Anti-tumor Drug Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Anti-tumor Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
In China, Anti-tumor Drug key players include AstraZeneca, Merck & Co., Roche, Celgene, Johnson & Johnson, etc.
United States is the largest market, followed by Japan, and Europe.
LPI (LP Information)' newest research report, the “Anti-tumor Drug Industry Forecast” looks at past sales and reviews total world Anti-tumor Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-tumor Drug sales for 2025 through 2031. With Anti-tumor Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-tumor Drug industry.
This Insight Report provides a comprehensive analysis of the global Anti-tumor Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-tumor Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-tumor Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-tumor Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-tumor Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-tumor Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Anti-tumor Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
In China, Anti-tumor Drug key players include AstraZeneca, Merck & Co., Roche, Celgene, Johnson & Johnson, etc.
United States is the largest market, followed by Japan, and Europe.
LPI (LP Information)' newest research report, the “Anti-tumor Drug Industry Forecast” looks at past sales and reviews total world Anti-tumor Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-tumor Drug sales for 2025 through 2031. With Anti-tumor Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-tumor Drug industry.
This Insight Report provides a comprehensive analysis of the global Anti-tumor Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-tumor Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-tumor Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-tumor Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-tumor Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-tumor Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cytotoxic Drugs
- Non-cytotoxic Drugs
- Alkylating Agents
- Anti-Metabolism Drugs
- Platinum Antineoplastic Agents
- Anthracycline Antitumor Drugs
- Microtubule Stabilizer
- Endocrine Therapy Drugs
- Immunotherapy Drugs
- Gene Therapy Drugs
- Targeted Antineoplastic Drugs
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Novartis
- Celgene
- Bristol-Myers Squibb
- Amgen
- Johnson & Johnson
- Pfizer
- Takeda
- Eli Lilly
- AstraZeneca
- Astellas
- Merck & Co
- Sanofi
- Bayer
- Biogen Idec
- Eisai
- Teva
- Otsuka
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-tumor Drug Market Size (2020-2031)
2.1.2 Anti-tumor Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Anti-tumor Drug by Country/Region (2020, 2024 & 2031)
2.2 Anti-tumor Drug Segment by Type
2.2.1 Cytotoxic Drugs
2.2.2 Non-cytotoxic Drugs
2.3 Anti-tumor Drug Market Size by Type
2.3.1 Anti-tumor Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Anti-tumor Drug Market Size Market Share by Type (2020-2025)
2.4 Anti-tumor Drug Segment by Application
2.4.1 Alkylating Agents
2.4.2 Anti-Metabolism Drugs
2.4.3 Platinum Antineoplastic Agents
2.4.4 Anthracycline Antitumor Drugs
2.4.5 Microtubule Stabilizer
2.4.6 Endocrine Therapy Drugs
2.4.7 Immunotherapy Drugs
2.4.8 Gene Therapy Drugs
2.4.9 Targeted Antineoplastic Drugs
2.5 Anti-tumor Drug Market Size by Application
2.5.1 Anti-tumor Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Anti-tumor Drug Market Size Market Share by Application (2020-2025)
3 ANTI-TUMOR DRUG MARKET SIZE BY PLAYER
3.1 Anti-tumor Drug Market Size Market Share by Player
3.1.1 Global Anti-tumor Drug Revenue by Player (2020-2025)
3.1.2 Global Anti-tumor Drug Revenue Market Share by Player (2020-2025)
3.2 Global Anti-tumor Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-TUMOR DRUG BY REGION
4.1 Anti-tumor Drug Market Size by Region (2020-2025)
4.2 Global Anti-tumor Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-tumor Drug Market Size Growth (2020-2025)
4.4 APAC Anti-tumor Drug Market Size Growth (2020-2025)
4.5 Europe Anti-tumor Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Anti-tumor Drug Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Anti-tumor Drug Market Size by Country (2020-2025)
5.2 Americas Anti-tumor Drug Market Size by Type (2020-2025)
5.3 Americas Anti-tumor Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-tumor Drug Market Size by Region (2020-2025)
6.2 APAC Anti-tumor Drug Market Size by Type (2020-2025)
6.3 APAC Anti-tumor Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-tumor Drug Market Size by Country (2020-2025)
7.2 Europe Anti-tumor Drug Market Size by Type (2020-2025)
7.3 Europe Anti-tumor Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-tumor Drug by Region (2020-2025)
8.2 Middle East & Africa Anti-tumor Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Anti-tumor Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-TUMOR DRUG MARKET FORECAST
10.1 Global Anti-tumor Drug Forecast by Region (2026-2031)
10.1.1 Global Anti-tumor Drug Forecast by Region (2026-2031)
10.1.2 Americas Anti-tumor Drug Forecast
10.1.3 APAC Anti-tumor Drug Forecast
10.1.4 Europe Anti-tumor Drug Forecast
10.1.5 Middle East & Africa Anti-tumor Drug Forecast
10.2 Americas Anti-tumor Drug Forecast by Country (2026-2031)
10.2.1 United States Market Anti-tumor Drug Forecast
10.2.2 Canada Market Anti-tumor Drug Forecast
10.2.3 Mexico Market Anti-tumor Drug Forecast
10.2.4 Brazil Market Anti-tumor Drug Forecast
10.3 APAC Anti-tumor Drug Forecast by Region (2026-2031)
10.3.1 China Anti-tumor Drug Market Forecast
10.3.2 Japan Market Anti-tumor Drug Forecast
10.3.3 Korea Market Anti-tumor Drug Forecast
10.3.4 Southeast Asia Market Anti-tumor Drug Forecast
10.3.5 India Market Anti-tumor Drug Forecast
10.3.6 Australia Market Anti-tumor Drug Forecast
10.4 Europe Anti-tumor Drug Forecast by Country (2026-2031)
10.4.1 Germany Market Anti-tumor Drug Forecast
10.4.2 France Market Anti-tumor Drug Forecast
10.4.3 UK Market Anti-tumor Drug Forecast
10.4.4 Italy Market Anti-tumor Drug Forecast
10.4.5 Russia Market Anti-tumor Drug Forecast
10.5 Middle East & Africa Anti-tumor Drug Forecast by Region (2026-2031)
10.5.1 Egypt Market Anti-tumor Drug Forecast
10.5.2 South Africa Market Anti-tumor Drug Forecast
10.5.3 Israel Market Anti-tumor Drug Forecast
10.5.4 Turkey Market Anti-tumor Drug Forecast
10.6 Global Anti-tumor Drug Forecast by Type (2026-2031)
10.7 Global Anti-tumor Drug Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Anti-tumor Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Anti-tumor Drug Product Offered
11.1.3 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Anti-tumor Drug Product Offered
11.2.3 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Celgene
11.3.1 Celgene Company Information
11.3.2 Celgene Anti-tumor Drug Product Offered
11.3.3 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Celgene Main Business Overview
11.3.5 Celgene Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Anti-tumor Drug Product Offered
11.4.3 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Amgen
11.5.1 Amgen Company Information
11.5.2 Amgen Anti-tumor Drug Product Offered
11.5.3 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Amgen Main Business Overview
11.5.5 Amgen Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Anti-tumor Drug Product Offered
11.6.3 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Anti-tumor Drug Product Offered
11.7.3 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Anti-tumor Drug Product Offered
11.8.3 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Anti-tumor Drug Product Offered
11.9.3 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Eli Lilly Main Business Overview
11.9.5 Eli Lilly Latest Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Anti-tumor Drug Product Offered
11.10.3 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 AstraZeneca Main Business Overview
11.10.5 AstraZeneca Latest Developments
11.11 Astellas
11.11.1 Astellas Company Information
11.11.2 Astellas Anti-tumor Drug Product Offered
11.11.3 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Astellas Main Business Overview
11.11.5 Astellas Latest Developments
11.12 Merck & Co
11.12.1 Merck & Co Company Information
11.12.2 Merck & Co Anti-tumor Drug Product Offered
11.12.3 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Merck & Co Main Business Overview
11.12.5 Merck & Co Latest Developments
11.13 Sanofi
11.13.1 Sanofi Company Information
11.13.2 Sanofi Anti-tumor Drug Product Offered
11.13.3 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Sanofi Main Business Overview
11.13.5 Sanofi Latest Developments
11.14 Bayer
11.14.1 Bayer Company Information
11.14.2 Bayer Anti-tumor Drug Product Offered
11.14.3 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Bayer Main Business Overview
11.14.5 Bayer Latest Developments
11.15 Biogen Idec
11.15.1 Biogen Idec Company Information
11.15.2 Biogen Idec Anti-tumor Drug Product Offered
11.15.3 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Biogen Idec Main Business Overview
11.15.5 Biogen Idec Latest Developments
11.16 Eisai
11.16.1 Eisai Company Information
11.16.2 Eisai Anti-tumor Drug Product Offered
11.16.3 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Eisai Main Business Overview
11.16.5 Eisai Latest Developments
11.17 Teva
11.17.1 Teva Company Information
11.17.2 Teva Anti-tumor Drug Product Offered
11.17.3 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Teva Main Business Overview
11.17.5 Teva Latest Developments
11.18 Otsuka
11.18.1 Otsuka Company Information
11.18.2 Otsuka Anti-tumor Drug Product Offered
11.18.3 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Otsuka Main Business Overview
11.18.5 Otsuka Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-tumor Drug Market Size (2020-2031)
2.1.2 Anti-tumor Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Anti-tumor Drug by Country/Region (2020, 2024 & 2031)
2.2 Anti-tumor Drug Segment by Type
2.2.1 Cytotoxic Drugs
2.2.2 Non-cytotoxic Drugs
2.3 Anti-tumor Drug Market Size by Type
2.3.1 Anti-tumor Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Anti-tumor Drug Market Size Market Share by Type (2020-2025)
2.4 Anti-tumor Drug Segment by Application
2.4.1 Alkylating Agents
2.4.2 Anti-Metabolism Drugs
2.4.3 Platinum Antineoplastic Agents
2.4.4 Anthracycline Antitumor Drugs
2.4.5 Microtubule Stabilizer
2.4.6 Endocrine Therapy Drugs
2.4.7 Immunotherapy Drugs
2.4.8 Gene Therapy Drugs
2.4.9 Targeted Antineoplastic Drugs
2.5 Anti-tumor Drug Market Size by Application
2.5.1 Anti-tumor Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Anti-tumor Drug Market Size Market Share by Application (2020-2025)
3 ANTI-TUMOR DRUG MARKET SIZE BY PLAYER
3.1 Anti-tumor Drug Market Size Market Share by Player
3.1.1 Global Anti-tumor Drug Revenue by Player (2020-2025)
3.1.2 Global Anti-tumor Drug Revenue Market Share by Player (2020-2025)
3.2 Global Anti-tumor Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTI-TUMOR DRUG BY REGION
4.1 Anti-tumor Drug Market Size by Region (2020-2025)
4.2 Global Anti-tumor Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-tumor Drug Market Size Growth (2020-2025)
4.4 APAC Anti-tumor Drug Market Size Growth (2020-2025)
4.5 Europe Anti-tumor Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Anti-tumor Drug Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Anti-tumor Drug Market Size by Country (2020-2025)
5.2 Americas Anti-tumor Drug Market Size by Type (2020-2025)
5.3 Americas Anti-tumor Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-tumor Drug Market Size by Region (2020-2025)
6.2 APAC Anti-tumor Drug Market Size by Type (2020-2025)
6.3 APAC Anti-tumor Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anti-tumor Drug Market Size by Country (2020-2025)
7.2 Europe Anti-tumor Drug Market Size by Type (2020-2025)
7.3 Europe Anti-tumor Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-tumor Drug by Region (2020-2025)
8.2 Middle East & Africa Anti-tumor Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Anti-tumor Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTI-TUMOR DRUG MARKET FORECAST
10.1 Global Anti-tumor Drug Forecast by Region (2026-2031)
10.1.1 Global Anti-tumor Drug Forecast by Region (2026-2031)
10.1.2 Americas Anti-tumor Drug Forecast
10.1.3 APAC Anti-tumor Drug Forecast
10.1.4 Europe Anti-tumor Drug Forecast
10.1.5 Middle East & Africa Anti-tumor Drug Forecast
10.2 Americas Anti-tumor Drug Forecast by Country (2026-2031)
10.2.1 United States Market Anti-tumor Drug Forecast
10.2.2 Canada Market Anti-tumor Drug Forecast
10.2.3 Mexico Market Anti-tumor Drug Forecast
10.2.4 Brazil Market Anti-tumor Drug Forecast
10.3 APAC Anti-tumor Drug Forecast by Region (2026-2031)
10.3.1 China Anti-tumor Drug Market Forecast
10.3.2 Japan Market Anti-tumor Drug Forecast
10.3.3 Korea Market Anti-tumor Drug Forecast
10.3.4 Southeast Asia Market Anti-tumor Drug Forecast
10.3.5 India Market Anti-tumor Drug Forecast
10.3.6 Australia Market Anti-tumor Drug Forecast
10.4 Europe Anti-tumor Drug Forecast by Country (2026-2031)
10.4.1 Germany Market Anti-tumor Drug Forecast
10.4.2 France Market Anti-tumor Drug Forecast
10.4.3 UK Market Anti-tumor Drug Forecast
10.4.4 Italy Market Anti-tumor Drug Forecast
10.4.5 Russia Market Anti-tumor Drug Forecast
10.5 Middle East & Africa Anti-tumor Drug Forecast by Region (2026-2031)
10.5.1 Egypt Market Anti-tumor Drug Forecast
10.5.2 South Africa Market Anti-tumor Drug Forecast
10.5.3 Israel Market Anti-tumor Drug Forecast
10.5.4 Turkey Market Anti-tumor Drug Forecast
10.6 Global Anti-tumor Drug Forecast by Type (2026-2031)
10.7 Global Anti-tumor Drug Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Anti-tumor Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Anti-tumor Drug Product Offered
11.1.3 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Anti-tumor Drug Product Offered
11.2.3 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Celgene
11.3.1 Celgene Company Information
11.3.2 Celgene Anti-tumor Drug Product Offered
11.3.3 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Celgene Main Business Overview
11.3.5 Celgene Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Anti-tumor Drug Product Offered
11.4.3 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Amgen
11.5.1 Amgen Company Information
11.5.2 Amgen Anti-tumor Drug Product Offered
11.5.3 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Amgen Main Business Overview
11.5.5 Amgen Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Anti-tumor Drug Product Offered
11.6.3 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Anti-tumor Drug Product Offered
11.7.3 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Anti-tumor Drug Product Offered
11.8.3 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Anti-tumor Drug Product Offered
11.9.3 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Eli Lilly Main Business Overview
11.9.5 Eli Lilly Latest Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Anti-tumor Drug Product Offered
11.10.3 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 AstraZeneca Main Business Overview
11.10.5 AstraZeneca Latest Developments
11.11 Astellas
11.11.1 Astellas Company Information
11.11.2 Astellas Anti-tumor Drug Product Offered
11.11.3 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Astellas Main Business Overview
11.11.5 Astellas Latest Developments
11.12 Merck & Co
11.12.1 Merck & Co Company Information
11.12.2 Merck & Co Anti-tumor Drug Product Offered
11.12.3 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Merck & Co Main Business Overview
11.12.5 Merck & Co Latest Developments
11.13 Sanofi
11.13.1 Sanofi Company Information
11.13.2 Sanofi Anti-tumor Drug Product Offered
11.13.3 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Sanofi Main Business Overview
11.13.5 Sanofi Latest Developments
11.14 Bayer
11.14.1 Bayer Company Information
11.14.2 Bayer Anti-tumor Drug Product Offered
11.14.3 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Bayer Main Business Overview
11.14.5 Bayer Latest Developments
11.15 Biogen Idec
11.15.1 Biogen Idec Company Information
11.15.2 Biogen Idec Anti-tumor Drug Product Offered
11.15.3 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Biogen Idec Main Business Overview
11.15.5 Biogen Idec Latest Developments
11.16 Eisai
11.16.1 Eisai Company Information
11.16.2 Eisai Anti-tumor Drug Product Offered
11.16.3 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Eisai Main Business Overview
11.16.5 Eisai Latest Developments
11.17 Teva
11.17.1 Teva Company Information
11.17.2 Teva Anti-tumor Drug Product Offered
11.17.3 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Teva Main Business Overview
11.17.5 Teva Latest Developments
11.18 Otsuka
11.18.1 Otsuka Company Information
11.18.2 Otsuka Anti-tumor Drug Product Offered
11.18.3 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Otsuka Main Business Overview
11.18.5 Otsuka Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-tumor Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Anti-tumor Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cytotoxic Drugs
Table 4. Major Players of Non-cytotoxic Drugs
Table 5. Anti-tumor Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Anti-tumor Drug Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Anti-tumor Drug Market Size Market Share by Type (2020-2025)
Table 8. Anti-tumor Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Anti-tumor Drug Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Anti-tumor Drug Market Size Market Share by Application (2020-2025)
Table 11. Global Anti-tumor Drug Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Anti-tumor Drug Revenue Market Share by Player (2020-2025)
Table 13. Anti-tumor Drug Key Players Head office and Products Offered
Table 14. Anti-tumor Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Anti-tumor Drug Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Anti-tumor Drug Market Size Market Share by Region (2020-2025)
Table 19. Global Anti-tumor Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Anti-tumor Drug Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Anti-tumor Drug Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Anti-tumor Drug Market Size Market Share by Country (2020-2025)
Table 23. Americas Anti-tumor Drug Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Anti-tumor Drug Market Size Market Share by Type (2020-2025)
Table 25. Americas Anti-tumor Drug Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Anti-tumor Drug Market Size Market Share by Application (2020-2025)
Table 27. APAC Anti-tumor Drug Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Anti-tumor Drug Market Size Market Share by Region (2020-2025)
Table 29. APAC Anti-tumor Drug Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Anti-tumor Drug Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Anti-tumor Drug Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Anti-tumor Drug Market Size Market Share by Country (2020-2025)
Table 33. Europe Anti-tumor Drug Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Anti-tumor Drug Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Anti-tumor Drug Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Anti-tumor Drug Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Anti-tumor Drug Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Anti-tumor Drug
Table 39. Key Market Challenges & Risks of Anti-tumor Drug
Table 40. Key Industry Trends of Anti-tumor Drug
Table 41. Global Anti-tumor Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Anti-tumor Drug Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Anti-tumor Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Anti-tumor Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Roche Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 46. Roche Anti-tumor Drug Product Offered
Table 47. Roche Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Roche Main Business
Table 49. Roche Latest Developments
Table 50. Novartis Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 51. Novartis Anti-tumor Drug Product Offered
Table 52. Novartis Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Celgene Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 56. Celgene Anti-tumor Drug Product Offered
Table 57. Celgene Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Celgene Main Business
Table 59. Celgene Latest Developments
Table 60. Bristol-Myers Squibb Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 61. Bristol-Myers Squibb Anti-tumor Drug Product Offered
Table 62. Bristol-Myers Squibb Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bristol-Myers Squibb Main Business
Table 64. Bristol-Myers Squibb Latest Developments
Table 65. Amgen Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 66. Amgen Anti-tumor Drug Product Offered
Table 67. Amgen Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Amgen Main Business
Table 69. Amgen Latest Developments
Table 70. Johnson & Johnson Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 71. Johnson & Johnson Anti-tumor Drug Product Offered
Table 72. Johnson & Johnson Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Johnson & Johnson Main Business
Table 74. Johnson & Johnson Latest Developments
Table 75. Pfizer Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 76. Pfizer Anti-tumor Drug Product Offered
Table 77. Pfizer Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Takeda Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 81. Takeda Anti-tumor Drug Product Offered
Table 82. Takeda Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Takeda Main Business
Table 84. Takeda Latest Developments
Table 85. Eli Lilly Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 86. Eli Lilly Anti-tumor Drug Product Offered
Table 87. Eli Lilly Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Eli Lilly Main Business
Table 89. Eli Lilly Latest Developments
Table 90. AstraZeneca Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 91. AstraZeneca Anti-tumor Drug Product Offered
Table 92. AstraZeneca Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. AstraZeneca Main Business
Table 94. AstraZeneca Latest Developments
Table 95. Astellas Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 96. Astellas Anti-tumor Drug Product Offered
Table 97. Astellas Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Astellas Main Business
Table 99. Astellas Latest Developments
Table 100. Merck & Co Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 101. Merck & Co Anti-tumor Drug Product Offered
Table 102. Merck & Co Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Merck & Co Main Business
Table 104. Merck & Co Latest Developments
Table 105. Sanofi Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 106. Sanofi Anti-tumor Drug Product Offered
Table 107. Sanofi Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Sanofi Main Business
Table 109. Sanofi Latest Developments
Table 110. Bayer Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 111. Bayer Anti-tumor Drug Product Offered
Table 112. Bayer Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Bayer Main Business
Table 114. Bayer Latest Developments
Table 115. Biogen Idec Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 116. Biogen Idec Anti-tumor Drug Product Offered
Table 117. Biogen Idec Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Biogen Idec Main Business
Table 119. Biogen Idec Latest Developments
Table 120. Eisai Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 121. Eisai Anti-tumor Drug Product Offered
Table 122. Eisai Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Eisai Main Business
Table 124. Eisai Latest Developments
Table 125. Teva Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 126. Teva Anti-tumor Drug Product Offered
Table 127. Teva Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Teva Main Business
Table 129. Teva Latest Developments
Table 130. Otsuka Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 131. Otsuka Anti-tumor Drug Product Offered
Table 132. Otsuka Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Otsuka Main Business
Table 134. Otsuka Latest Developments
Table 1. Anti-tumor Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Anti-tumor Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cytotoxic Drugs
Table 4. Major Players of Non-cytotoxic Drugs
Table 5. Anti-tumor Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Anti-tumor Drug Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Anti-tumor Drug Market Size Market Share by Type (2020-2025)
Table 8. Anti-tumor Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Anti-tumor Drug Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Anti-tumor Drug Market Size Market Share by Application (2020-2025)
Table 11. Global Anti-tumor Drug Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Anti-tumor Drug Revenue Market Share by Player (2020-2025)
Table 13. Anti-tumor Drug Key Players Head office and Products Offered
Table 14. Anti-tumor Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Anti-tumor Drug Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Anti-tumor Drug Market Size Market Share by Region (2020-2025)
Table 19. Global Anti-tumor Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Anti-tumor Drug Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Anti-tumor Drug Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Anti-tumor Drug Market Size Market Share by Country (2020-2025)
Table 23. Americas Anti-tumor Drug Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Anti-tumor Drug Market Size Market Share by Type (2020-2025)
Table 25. Americas Anti-tumor Drug Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Anti-tumor Drug Market Size Market Share by Application (2020-2025)
Table 27. APAC Anti-tumor Drug Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Anti-tumor Drug Market Size Market Share by Region (2020-2025)
Table 29. APAC Anti-tumor Drug Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Anti-tumor Drug Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Anti-tumor Drug Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Anti-tumor Drug Market Size Market Share by Country (2020-2025)
Table 33. Europe Anti-tumor Drug Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Anti-tumor Drug Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Anti-tumor Drug Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Anti-tumor Drug Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Anti-tumor Drug Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Anti-tumor Drug
Table 39. Key Market Challenges & Risks of Anti-tumor Drug
Table 40. Key Industry Trends of Anti-tumor Drug
Table 41. Global Anti-tumor Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Anti-tumor Drug Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Anti-tumor Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Anti-tumor Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Roche Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 46. Roche Anti-tumor Drug Product Offered
Table 47. Roche Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Roche Main Business
Table 49. Roche Latest Developments
Table 50. Novartis Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 51. Novartis Anti-tumor Drug Product Offered
Table 52. Novartis Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Celgene Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 56. Celgene Anti-tumor Drug Product Offered
Table 57. Celgene Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Celgene Main Business
Table 59. Celgene Latest Developments
Table 60. Bristol-Myers Squibb Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 61. Bristol-Myers Squibb Anti-tumor Drug Product Offered
Table 62. Bristol-Myers Squibb Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bristol-Myers Squibb Main Business
Table 64. Bristol-Myers Squibb Latest Developments
Table 65. Amgen Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 66. Amgen Anti-tumor Drug Product Offered
Table 67. Amgen Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Amgen Main Business
Table 69. Amgen Latest Developments
Table 70. Johnson & Johnson Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 71. Johnson & Johnson Anti-tumor Drug Product Offered
Table 72. Johnson & Johnson Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Johnson & Johnson Main Business
Table 74. Johnson & Johnson Latest Developments
Table 75. Pfizer Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 76. Pfizer Anti-tumor Drug Product Offered
Table 77. Pfizer Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Takeda Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 81. Takeda Anti-tumor Drug Product Offered
Table 82. Takeda Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Takeda Main Business
Table 84. Takeda Latest Developments
Table 85. Eli Lilly Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 86. Eli Lilly Anti-tumor Drug Product Offered
Table 87. Eli Lilly Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Eli Lilly Main Business
Table 89. Eli Lilly Latest Developments
Table 90. AstraZeneca Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 91. AstraZeneca Anti-tumor Drug Product Offered
Table 92. AstraZeneca Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. AstraZeneca Main Business
Table 94. AstraZeneca Latest Developments
Table 95. Astellas Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 96. Astellas Anti-tumor Drug Product Offered
Table 97. Astellas Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Astellas Main Business
Table 99. Astellas Latest Developments
Table 100. Merck & Co Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 101. Merck & Co Anti-tumor Drug Product Offered
Table 102. Merck & Co Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Merck & Co Main Business
Table 104. Merck & Co Latest Developments
Table 105. Sanofi Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 106. Sanofi Anti-tumor Drug Product Offered
Table 107. Sanofi Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Sanofi Main Business
Table 109. Sanofi Latest Developments
Table 110. Bayer Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 111. Bayer Anti-tumor Drug Product Offered
Table 112. Bayer Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Bayer Main Business
Table 114. Bayer Latest Developments
Table 115. Biogen Idec Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 116. Biogen Idec Anti-tumor Drug Product Offered
Table 117. Biogen Idec Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Biogen Idec Main Business
Table 119. Biogen Idec Latest Developments
Table 120. Eisai Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 121. Eisai Anti-tumor Drug Product Offered
Table 122. Eisai Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Eisai Main Business
Table 124. Eisai Latest Developments
Table 125. Teva Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 126. Teva Anti-tumor Drug Product Offered
Table 127. Teva Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Teva Main Business
Table 129. Teva Latest Developments
Table 130. Otsuka Details, Company Type, Anti-tumor Drug Area Served and Its Competitors
Table 131. Otsuka Anti-tumor Drug Product Offered
Table 132. Otsuka Anti-tumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Otsuka Main Business
Table 134. Otsuka Latest Developments
LIST OF FIGURES
Figure 1. Anti-tumor Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-tumor Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Anti-tumor Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Anti-tumor Drug Sales Market Share by Country/Region (2024)
Figure 8. Anti-tumor Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Anti-tumor Drug Market Size Market Share by Type in 2024
Figure 10. Anti-tumor Drug in Alkylating Agents
Figure 11. Global Anti-tumor Drug Market: Alkylating Agents (2020-2025) & ($ millions)
Figure 12. Anti-tumor Drug in Anti-Metabolism Drugs
Figure 13. Global Anti-tumor Drug Market: Anti-Metabolism Drugs (2020-2025) & ($ millions)
Figure 14. Anti-tumor Drug in Platinum Antineoplastic Agents
Figure 15. Global Anti-tumor Drug Market: Platinum Antineoplastic Agents (2020-2025) & ($ millions)
Figure 16. Anti-tumor Drug in Anthracycline Antitumor Drugs
Figure 17. Global Anti-tumor Drug Market: Anthracycline Antitumor Drugs (2020-2025) & ($ millions)
Figure 18. Anti-tumor Drug in Microtubule Stabilizer
Figure 19. Global Anti-tumor Drug Market: Microtubule Stabilizer (2020-2025) & ($ millions)
Figure 20. Anti-tumor Drug in Endocrine Therapy Drugs
Figure 21. Global Anti-tumor Drug Market: Endocrine Therapy Drugs (2020-2025) & ($ millions)
Figure 22. Anti-tumor Drug in Immunotherapy Drugs
Figure 23. Global Anti-tumor Drug Market: Immunotherapy Drugs (2020-2025) & ($ millions)
Figure 24. Anti-tumor Drug in Gene Therapy Drugs
Figure 25. Global Anti-tumor Drug Market: Gene Therapy Drugs (2020-2025) & ($ millions)
Figure 26. Anti-tumor Drug in Targeted Antineoplastic Drugs
Figure 27. Global Anti-tumor Drug Market: Targeted Antineoplastic Drugs (2020-2025) & ($ millions)
Figure 28. Global Anti-tumor Drug Market Size Market Share by Application in 2024
Figure 29. Global Anti-tumor Drug Revenue Market Share by Player in 2024
Figure 30. Global Anti-tumor Drug Market Size Market Share by Region (2020-2025)
Figure 31. Americas Anti-tumor Drug Market Size 2020-2025 ($ millions)
Figure 32. APAC Anti-tumor Drug Market Size 2020-2025 ($ millions)
Figure 33. Europe Anti-tumor Drug Market Size 2020-2025 ($ millions)
Figure 34. Middle East & Africa Anti-tumor Drug Market Size 2020-2025 ($ millions)
Figure 35. Americas Anti-tumor Drug Value Market Share by Country in 2024
Figure 36. United States Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Canada Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 38. Mexico Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 39. Brazil Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 40. APAC Anti-tumor Drug Market Size Market Share by Region in 2024
Figure 41. APAC Anti-tumor Drug Market Size Market Share by Type (2020-2025)
Figure 42. APAC Anti-tumor Drug Market Size Market Share by Application (2020-2025)
Figure 43. China Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Japan Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. South Korea Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 46. Southeast Asia Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 47. India Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 48. Australia Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. Europe Anti-tumor Drug Market Size Market Share by Country in 2024
Figure 50. Europe Anti-tumor Drug Market Size Market Share by Type (2020-2025)
Figure 51. Europe Anti-tumor Drug Market Size Market Share by Application (2020-2025)
Figure 52. Germany Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. France Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 54. UK Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 55. Italy Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 56. Russia Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 57. Middle East & Africa Anti-tumor Drug Market Size Market Share by Region (2020-2025)
Figure 58. Middle East & Africa Anti-tumor Drug Market Size Market Share by Type (2020-2025)
Figure 59. Middle East & Africa Anti-tumor Drug Market Size Market Share by Application (2020-2025)
Figure 60. Egypt Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 61. South Africa Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 62. Israel Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 63. Turkey Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 64. GCC Countries Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 65. Americas Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 66. APAC Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 67. Europe Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 68. Middle East & Africa Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 69. United States Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 70. Canada Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 71. Mexico Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 72. Brazil Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 73. China Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 74. Japan Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 75. Korea Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 76. Southeast Asia Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 77. India Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 78. Australia Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 79. Germany Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 80. France Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 81. UK Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 82. Italy Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 83. Russia Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 84. Egypt Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 85. South Africa Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 86. Israel Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 87. Turkey Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 88. Global Anti-tumor Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 89. Global Anti-tumor Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 90. GCC Countries Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 1. Anti-tumor Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-tumor Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Anti-tumor Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Anti-tumor Drug Sales Market Share by Country/Region (2024)
Figure 8. Anti-tumor Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Anti-tumor Drug Market Size Market Share by Type in 2024
Figure 10. Anti-tumor Drug in Alkylating Agents
Figure 11. Global Anti-tumor Drug Market: Alkylating Agents (2020-2025) & ($ millions)
Figure 12. Anti-tumor Drug in Anti-Metabolism Drugs
Figure 13. Global Anti-tumor Drug Market: Anti-Metabolism Drugs (2020-2025) & ($ millions)
Figure 14. Anti-tumor Drug in Platinum Antineoplastic Agents
Figure 15. Global Anti-tumor Drug Market: Platinum Antineoplastic Agents (2020-2025) & ($ millions)
Figure 16. Anti-tumor Drug in Anthracycline Antitumor Drugs
Figure 17. Global Anti-tumor Drug Market: Anthracycline Antitumor Drugs (2020-2025) & ($ millions)
Figure 18. Anti-tumor Drug in Microtubule Stabilizer
Figure 19. Global Anti-tumor Drug Market: Microtubule Stabilizer (2020-2025) & ($ millions)
Figure 20. Anti-tumor Drug in Endocrine Therapy Drugs
Figure 21. Global Anti-tumor Drug Market: Endocrine Therapy Drugs (2020-2025) & ($ millions)
Figure 22. Anti-tumor Drug in Immunotherapy Drugs
Figure 23. Global Anti-tumor Drug Market: Immunotherapy Drugs (2020-2025) & ($ millions)
Figure 24. Anti-tumor Drug in Gene Therapy Drugs
Figure 25. Global Anti-tumor Drug Market: Gene Therapy Drugs (2020-2025) & ($ millions)
Figure 26. Anti-tumor Drug in Targeted Antineoplastic Drugs
Figure 27. Global Anti-tumor Drug Market: Targeted Antineoplastic Drugs (2020-2025) & ($ millions)
Figure 28. Global Anti-tumor Drug Market Size Market Share by Application in 2024
Figure 29. Global Anti-tumor Drug Revenue Market Share by Player in 2024
Figure 30. Global Anti-tumor Drug Market Size Market Share by Region (2020-2025)
Figure 31. Americas Anti-tumor Drug Market Size 2020-2025 ($ millions)
Figure 32. APAC Anti-tumor Drug Market Size 2020-2025 ($ millions)
Figure 33. Europe Anti-tumor Drug Market Size 2020-2025 ($ millions)
Figure 34. Middle East & Africa Anti-tumor Drug Market Size 2020-2025 ($ millions)
Figure 35. Americas Anti-tumor Drug Value Market Share by Country in 2024
Figure 36. United States Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Canada Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 38. Mexico Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 39. Brazil Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 40. APAC Anti-tumor Drug Market Size Market Share by Region in 2024
Figure 41. APAC Anti-tumor Drug Market Size Market Share by Type (2020-2025)
Figure 42. APAC Anti-tumor Drug Market Size Market Share by Application (2020-2025)
Figure 43. China Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Japan Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. South Korea Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 46. Southeast Asia Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 47. India Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 48. Australia Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. Europe Anti-tumor Drug Market Size Market Share by Country in 2024
Figure 50. Europe Anti-tumor Drug Market Size Market Share by Type (2020-2025)
Figure 51. Europe Anti-tumor Drug Market Size Market Share by Application (2020-2025)
Figure 52. Germany Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. France Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 54. UK Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 55. Italy Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 56. Russia Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 57. Middle East & Africa Anti-tumor Drug Market Size Market Share by Region (2020-2025)
Figure 58. Middle East & Africa Anti-tumor Drug Market Size Market Share by Type (2020-2025)
Figure 59. Middle East & Africa Anti-tumor Drug Market Size Market Share by Application (2020-2025)
Figure 60. Egypt Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 61. South Africa Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 62. Israel Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 63. Turkey Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 64. GCC Countries Anti-tumor Drug Market Size Growth 2020-2025 ($ millions)
Figure 65. Americas Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 66. APAC Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 67. Europe Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 68. Middle East & Africa Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 69. United States Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 70. Canada Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 71. Mexico Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 72. Brazil Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 73. China Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 74. Japan Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 75. Korea Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 76. Southeast Asia Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 77. India Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 78. Australia Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 79. Germany Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 80. France Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 81. UK Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 82. Italy Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 83. Russia Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 84. Egypt Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 85. South Africa Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 86. Israel Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 87. Turkey Anti-tumor Drug Market Size 2026-2031 ($ millions)
Figure 88. Global Anti-tumor Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 89. Global Anti-tumor Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 90. GCC Countries Anti-tumor Drug Market Size 2026-2031 ($ millions)
More Publications
Global Anti-tumor Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
January 2026
135 pages
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anti-Tumor Drugs Market 2018, Forecast to 2023
US$ 4,880.00
January 2019
119 pages
